Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies.

Huilin Tang,Hui Shao,C Elizabeth Shaaban,Keming Yang,Joshua Brown,Stephen Anton,Yonghui Wu,Adam Bress,William T Donahoo,Steven T DeKosky,Jiang Bian,Jingchuan Guo

Journal of the American Geriatrics Society（2023）

引用 4|浏览52

暂无评分

摘要

Newer GLDs were associated with a decreased risk of all-cause dementia in people with T2D. Because of the observational nature and significant heterogeneity between studies, the results should be interpreted with caution. Further research is warranted to confirm our findings.

查看译文

关键词

DPP-4 inhibitors,GLP-1RAs,SGLT2 inhibitors,dementia,type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要